I think that you are right about the sector getting hammered. But if you look at the results of Pepper and Solvar they tell a very different story to CCV.
pepper has declining revenue, margins and profits. And Solnar also has issues like slow revenue growth relative to loan book growth. Decline EPS and losses at NPAT .
Half year profits in Feb (hopefully show strong profit growth) should be a catalyst for a rerating of this stock and will separate the from the pack.
fingers crossed.
Ann: CCV 2023 AGM Addresses and Presentation, page-6
Add CCV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.8¢ |
Change
0.008(3.75%) |
Mkt cap ! $128.6M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.8¢ | 20.5¢ | $3.107K | 15.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 58460 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 659283 | 9 |
View Market Depth
| Last trade - 12.43pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
20.8¢ |
Change
0.008 ( 1.22 %) |
||||
| Open | High | Low | Volume | ||
| 20.8¢ | 20.8¢ | 20.8¢ | 837 | ||
| Last updated 11.48am 05/06/2024 ? | |||||
| CCV (ASX) Chart |